Trial · NCT04369469
Participant flow12
How many started, completed or left each group, period by period.
1 to 12 of 12
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Group 1 - Ravulizumab + BSC | 135 | |
| Overall Study | STARTED | Group 2 - BSC Alone | 67 | |
| Overall Study | Intent to Treat (ITT) Population | Group 1 - Ravulizumab + BSC | 135 | |
| Overall Study | Intent to Treat (ITT) Population | Group 2 - BSC Alone | 66 | |
| Overall Study | Pharmacokinetic (PK) | Group 1 - Ravulizumab + BSC | 127 | |
| Overall Study | Pharmacokinetic (PK) | Group 2 - BSC Alone | 52 | |
| Overall Study | Safety Population | Group 1 - Ravulizumab + BSC | 127 | |
| Overall Study | Safety Population | Group 2 - BSC Alone | 67 | |
| Overall Study | COMPLETED | Group 1 - Ravulizumab + BSC | 125 | |
| Overall Study | COMPLETED | Group 2 - BSC Alone | 58 | |
| Overall Study | NOT COMPLETED | Group 1 - Ravulizumab + BSC | 10 | |
| Overall Study | NOT COMPLETED | Group 2 - BSC Alone | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04369469/flow